Infinity to Present At Upcoming Conferences
March 03, 2009 12:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
Infinity Well-Financed to Achieve 'I4 2012' Long-Term Goals; Announces 2008 Financial Results
February 09, 2009 16:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reiterated its "I4 2012" goals and...
Infinity Announces Hedgehog Pathway Preclinical Data in Ovarian Cancer
February 09, 2009 14:45 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the presentation of...
Infinity Announces Conference Call Discussing Fourth Quarter 2008 Results
February 02, 2009 17:45 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
Infinity Announces 2009 and Long-Term Goals, Building On 2008 Success
January 12, 2009 06:00 ET
|
Infinity Pharmaceuticals, Inc.
Begins 2009 With Four Years of Capital, Three Clinical Candidates
in Development, Two New INDs, and One Pivotal Trial
Introduces "I4 2012" Long-Term Goals
CAMBRIDGE,...
Infinity Announces Completion of Second Equity Investment by Purdue
January 08, 2009 08:03 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 8, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced that its shareholders have voted...
Infinity to Present At JP Morgan Healthcare Conference
January 06, 2009 08:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program
December 11, 2008 06:00 ET
|
Infinity Pharmaceuticals, Inc.
Infinity to Independently Develop Its Industry-Leading Hsp90 Program
Clinical Programs Continue to Advance On Schedule
CAMBRIDGE, Mass., Dec. 11, 2008 (GLOBE NEWSWIRE) -- Infinity...
Infinity to Present At Piper Jaffray 20th Annual Health Care Conference
November 26, 2008 13:45 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 26, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
Infinity Announces Global Strategic Alliance With Purdue Pharma and Mundipharma Encompassing Infinity's Early Clinical and Discovery Programs
November 20, 2008 06:00 ET
|
Infinity Pharmaceuticals, Inc.
Infinity Retains All U.S. Rights; Mundipharma Receives Ex-U.S.
Commercialization Rights to All Oncology Products Under Alliance
Infinity to Receive Up to $75 Million Equity...